LENZ Therapeutics, Inc. (LENZ)

Typically moves ±7.62% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-06 ESTIMATED

Across 17 earnings reports since Aug 12, 2021, LENZ Therapeutics, Inc. (LENZ) has a clear post-earnings pattern. It moves ±7.62% on average after reporting and finishes higher 35.3% of the time. Its largest post-earnings gain was +12.5% (Nov 06, 2024) and its largest decline was -23.46% (Nov 05, 2025). The next earnings report is predicted for 2026-11-06 (estimated).

Earnings reactions

How LENZ moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±7.62%

Positive %

35.3%

Negative %

64.7%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☽ POST	-3.26%	open_in_new
May 11, 2026	☽ POST	-20.94%	open_in_new
Mar 24, 2026	☀ PRE	-17.91%	open_in_new
Nov 05, 2025	☀ PRE	-23.46%	open_in_new
Jul 30, 2025	☀ PRE	-2.87%	open_in_new
May 07, 2025	☽ POST	+2.09%	open_in_new
Mar 19, 2025	☽ POST	+3.06%	open_in_new
Nov 06, 2024	☀ PRE	+12.5%	open_in_new
Aug 14, 2024	☽ POST	-3.83%	open_in_new
May 08, 2024	☽ POST	-4.82%	open_in_new
Mar 20, 2023	☽ POST	-4.12%	open_in_new
Nov 09, 2022	☽ POST	+3.03%	open_in_new
Aug 11, 2022	☽ POST	+2.27%	open_in_new
May 16, 2022	☀ PRE	-4.62%	open_in_new
Mar 21, 2022	☀ PRE	-15.15%	open_in_new
Nov 10, 2021	☽ POST	+3.85%	open_in_new
Aug 12, 2021	☽ POST	-1.82%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±7.62%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 19 →

Funds holding

$24776091

Total value held

Buying

12 added · 6 reduced

Blackrock, Inc.

$13019246 +15.95%

Morgan Stanley

$2686612 -27.10%

State Street Corp

$2309908 +1.11%

Bank Of America Corp /De/

$1450729 -53.35%

Jefferies Financial Group Inc.

$1137704 NEW BUY

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260908	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
8-K	20260702	open_in_new SEC.gov
SCHEDULE 13G	20260626	open_in_new SEC.gov
4	20260615	open_in_new SEC.gov
4	20260615	open_in_new SEC.gov
4	20260615	open_in_new SEC.gov
4	20260615	open_in_new SEC.gov
4	20260615	open_in_new SEC.gov

Frequently asked about LENZ earnings

When does LENZ Therapeutics, Inc. report earnings next? expand_more

LENZ Therapeutics, Inc. (LENZ)'s next earnings date is estimated for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does LENZ stock move after earnings? expand_more

Over 17 reports, LENZ has moved an average of ±7.62% the session after earnings, closing higher 35.3% of the time.

What was LENZ's biggest post-earnings move? expand_more

LENZ's largest post-earnings gain on record was +12.5% on Nov 06, 2024, and its largest decline was -23.46% on Nov 05, 2025.

Where can I find LENZ Therapeutics, Inc.'s SEC filings? expand_more

All of LENZ Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.